SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news

 

 
EFSA health claim opinion

EFSA pours cold water on glycaemia claim

By Shane Starling , 26-Feb-2009
Last updated on 24-Dec-2009 at 14:42 GMT2009-12-24T14:42:54Z

An article 14 disease risk reduction health claim linking mineral water consumption and a reduction of glycaemia has drawn a negative opinion from the European Food Safety Authority (EFSA).

The assessor’s Panel on Dietetic Products, Nutrition and Allergies (NDA) found Unicer Bebidas de Portugal SGPS’s claim did not demonstrate causality between drinking its mineral water, Melgaço, and reduced rates of glycaemia in glycaemic individuals.

It is the first claim the NDA has assessed in the area of hyperglycaemia, which the Portuguese company linked to a condition called type 2 diabetes mellitus in its dossier. But the NDA said the disease for which hyperglycaemia is a risk factor was not clearly specified.

The NDA highlighted several issues with the Portuguese company’s presented science of one human intervention study and two animal studies.

The human intervention study featured 100 subjects at a Melgaco spa with pathologies of the upper respiratory tract, of the osteo-articular system, or type 2 diabetes mellitus. Subjects who were hyperglycaemic but not diabetic were not specified.

No significant changes

When all subjects were considered together, fasting plasma glucose (FPG) levels significantly decreased after the 14-day intervention and significantly increased during the 9-month follow-up.

“FPG in these subjects significantly decreased after the 14-day intervention. No significant changes were observed in fasting plasma insulin or glycated haemoglobin during this period, or in FPG, fasting plasma insulin or glycated haemoglobin at the end of the 9-month follow-up as compared to the end of the intervention,” NDA said.

The trial was compromised by the undefined nature of the treatment (including the frequency and amount of Melgaço mineral water consumption), background diet and medication.

“The Panel considers that the significant weaknesses of this study greatly limit its value as a source of data to support the claimed effect.”

One of the animal studies was considered to have inconclusive data regarding the number of animals per group, statistical analyses used and quantitative results.

The other animal study looked at the effects of the Melgaço mineral water on glucose homeostasis, insulin secretion, and insulin resistance in diabetic Goto-Kakizaki rats (a model of type 2 diabetes) and in normal (non-diabetic) Wistar rats.

“The Panel considers that the significant weaknesses of this animal study (lack of adequate controls, no data available regarding the baseline characteristics of the animals nor on the changes observed in the intervention and control groups during the study) and the fact that results obtained in this experimental animal model cannot be extrapolated with any confidence to human subjects with hyperglycaemia greatly limit its value as a source of data to support the claimed effect.”

It therefore concluded causality had not been demonstrated.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars